Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00319566
Status:
COMPLETED
Last Update Posted:
2006-04-27
First Post:
2006-04-27
Brief Title:
Heart and Estrogen-Progestin Replacement Study HERS
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Study Overview
Official Title:
Heart and Estrogen-Progestin Replacement Study HERS
Status:
COMPLETED
Status Verified Date:
2002-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine whether hormone replacement therapy in post menopausal women with coronary artery disease prevents future heart attacks or death from coronary heart disease
Detailed Description:
A randomized blinded trial in post menopausal women with cornaornary artery disease to test the hypothesis among 2340 women who have a uterus that those randomized to receive estrogen-progestin replacement therapy Premanrin 625 mg daily plus medroxygrprogesterone acetate 25 mg daily have the same frequency on new CHD events myocardial infarction and CHD death as those randomized to placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None